Dalmevin 50 mg tablete

Name	Dalmevin 50 mg tablete
Marketing Authorisation Number	HR-H-215024398
Active Substance	vildagliptin
Composition	svaka tableta sadrži 50 mg vildagliptina
Pharmaceutical Form	tableta
Manufacturer	Medochemie Ltd., Limassol, Cipar
Marketing Authorisation Holder	Medochemie Ltd., Constatinoupoleos Str. 1-10, Limassol, Cipar
Marketing Authorisation Date	07.01.2022
MA Period of Validity	unlimited
Classification Number	UP/I-530-09/21-02/140
Registration Number	381-12-01/38-22-04
Prescription	Medicinal product subject to medical prescription
Type of prescription	Medicinal product on medical prescription for renewable delivery
Distribution	Supply through pharmacies (community)
Advertising to general public	not allowed
ATC Code	A10BH02
Marketing status	Marketed
Shortage status	No shortage
SmPC	download
PL	download
Public Assessment Report	download

Packaging description	MA Number for Packaging	Marketing status	Shortage status
7 tableta u blisteru, u kutiji	HR-H-215024398-01	-	-
14 tableta u blisteru, u kutiji	HR-H-215024398-02	-	-
28 tableta u blisteru, u kutiji	HR-H-215024398-03	-	-
30 tableta u blisteru, u kutiji	HR-H-215024398-04	-	-
56 tableta u blisteru, u kutiji	HR-H-215024398-05	Never marketed	-
60 tableta u blisteru, u kutiji	HR-H-215024398-06	Marketed	No shortage
90 tableta u blisteru, u kutiji	HR-H-215024398-07	-	-
112 tableta u blisteru, u kutiji	HR-H-215024398-08	-	-
180 tableta u blisteru, u kutiji	HR-H-215024398-09	-	-
336 tableta u blisteru, u kutiji	HR-H-215024398-10	-	-

Medicinal Products